Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Sep 25, 2023

BUY
$350.74 - $468.98 $8.54 Million - $11.4 Million
24,343 Added 419.85%
30,141 $14.1 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $8.54 Million - $11.4 Million
24,343 Added 419.85%
30,141 $14.1 Million
Q1 2023

Sep 25, 2023

SELL
$310.63 - $364.82 $7.56 Million - $8.88 Million
-24,343 Reduced 80.76%
5,798 $1.99 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $3.12 Million - $3.66 Million
-10,043 Reduced 63.4%
5,798 $1.99 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $2.34 Million - $2.73 Million
7,276 Added 84.95%
15,841 $5.8 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $13.1 Million - $14.9 Million
-44,066 Reduced 83.73%
8,565 $2.77 Million
Q2 2022

Nov 16, 2022

BUY
$278.73 - $327.27 $12.3 Million - $14.4 Million
44,066 Added 514.49%
52,631 $17.1 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $38,186 - $44,835
-137 Reduced 0.26%
52,631 $17.1 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $3.49 Million - $4.34 Million
14,876 Added 39.26%
52,768 $15.1 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $4.34 Million - $5.39 Million
19,318 Added 104.01%
37,892 $10.5 Million
Q3 2021

Nov 16, 2021

BUY
$221.6 - $272.71 $602,752 - $741,771
2,720 Added 17.16%
18,574 $4.29 Million
Q2 2021

Aug 17, 2021

BUY
$180.55 - $233.54 $2.45 Million - $3.17 Million
13,574 Added 595.35%
15,854 $3.64 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $3.04 Million - $3.93 Million
-18,490 Reduced 89.02%
2,280 $425,000
Q3 2016

Aug 24, 2017

SELL
N/A
-10,130 Reduced 32.78%
20,770 $1.67 Million
Q2 2016

Aug 24, 2017

BUY
N/A
30,900
30,900 $2.43 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Brookfield Asset Management Inc. Portfolio

Follow Brookfield Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brookfield Asset Management Inc. with notifications on news.